Samsung Bioepis and Teva Pharmaceutical Industries have expanded their partnership with a global agreement covering up to six ...
The data add to the evidence behind ecopipam as the drug awaits a decision from the US Food and Drug Administration under ...
The rebrand is aimed at reflecting SPI Pharma’s evolution and its focus on helping customers tackle increasingly complex ...
Abbott said SimpleScreen CRC is designed primarily for eligible patients who decline or do not complete preferred stool-based ...
Aurobindo Pharma Limited has secured final approval from the US Food & Drug Administration (USFDA) to manufacture and market ...
Regeneron will receive $1 billion upfront from Sanofi, with up to $7 billion more available through development, regulatory ...
The companies plan to begin with a Phase III study in patients with previously untreated triple-negative breast cancer ...
“LITFULO has dual selectivity for JAK3 and the TEC family kinases, signals that immune cells use to attack pigment-producing ...
The industry's more rigorous players are likely to pull further ahead over the coming years, not through any single ...
We are expanding into the Middle East, Southeast Asia and Africa, where high musculoskeletal disease burden, growing private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results